Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Melanoma, Stage II, Stage I”

229 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 229 results

Not applicableLooking for participantsNCT06643286
What this trial is testing

Evaluation of a Personalised Survivorship Care Plan App for Patients With Melanoma

Who this might be right for
Melanoma (Skin)Melanoma, Stage II, Stage IMelanoma Stage+1 more
Erasmus Medical Center 180
Testing effectiveness (Phase 2)Study completedNCT02404441
What this trial is testing

Phase I/II Study of PDR001 in Patients With Advanced Malignancies

Who this might be right for
MelanomaNon-small Sell Lung Cancer (NSCLC)Triple Negative Breast Cancer+2 more
Novartis Pharmaceuticals 319
Testing effectiveness (Phase 2)Ended earlyNCT02706353
What this trial is testing

APX005M in Combination With Systemic Pembrolizumab in Patients With Metastatic Melanoma

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 34
Testing effectiveness (Phase 2)Ended earlyNCT01350401
What this trial is testing

Phase I/II Study to Assess the Safety and Activity of Enhanced TCR Transduced Autologous T Cells in Metastatic Melanoma

Who this might be right for
Melanoma
Adaptimmune 4
Testing effectiveness (Phase 2)Ended earlyNCT00924001
What this trial is testing

Chemotherapy Followed by Infusion of DMF5 Cells to Treat Metastatic Melanoma

Who this might be right for
MelanomaMalignant MelanomaMelanoma, Experimental
National Cancer Institute (NCI) 1
Testing effectiveness (Phase 2)Looking for participantsNCT06626516
What this trial is testing

Tebentafusp-tebn With LDT in Metastatic UM

Who this might be right for
Metastatic Uveal Melanoma
Thomas Jefferson University 109
Not applicableStudy completedNCT02975700
What this trial is testing

PLX3397 in Patients With Unresectable or Metastatic KIT-mutated Melanoma

Who this might be right for
Melanoma
Daiichi Sankyo Co., Ltd. 6
Testing effectiveness (Phase 2)Study completedNCT00818480
What this trial is testing

An Extension Study Administering YM155 to Subjects Previously Enrolled in Another Protocol Administering YM155

Who this might be right for
Prostate CancerMelanomaNon-Hodgkin's Lymphoma
Astellas Pharma Inc 10
Testing effectiveness (Phase 2)Ended earlyNCT02153905
What this trial is testing

T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-A*01 Positive

Who this might be right for
Breast CancerCervical CancerRenal Cancer+2 more
National Cancer Institute (NCI) 3
Not applicableStudy completedNCT00900302
What this trial is testing

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Who this might be right for
Cancer
OHSU Knight Cancer Institute 98
Testing effectiveness (Phase 2)Study completedNCT01189383
What this trial is testing

IL15 Dendritic Cell Vaccine for Patients With Resected Stage III (A, B or C) or Stage IV Melanoma

Who this might be right for
Malignant Melanoma Stage IIIMalignant Melanoma Stage IV
Baylor Research Institute 20
Early research (Phase 1)Active Not RecruitingNCT01590069
What this trial is testing

Aerosolized Aldesleukin in Treating Patients With Lung Metastases

Who this might be right for
Metastatic Malignant Neoplasm in the LungMetastatic MelanomaMetastatic Osteosarcoma+5 more
M.D. Anderson Cancer Center 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT02068586
What this trial is testing

Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma

Who this might be right for
Ciliary Body and Choroid Melanoma, Medium/Large SizeCiliary Body and Choroid Melanoma, Small SizeIris Melanoma+9 more
Sidney Kimmel Cancer Center at Thomas Jefferson University 210
Testing effectiveness (Phase 2)Ended earlyNCT00945269
What this trial is testing

Therapeutic Autologous Lymphocytes, Aldesleukin, and Denileukin Diftitox in Treating Patients With Stage III-IV Melanoma

Who this might be right for
Recurrent MelanomaStage III MelanomaStage IV Melanoma
Fred Hutchinson Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT00948961
What this trial is testing

CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1

Who this might be right for
Advanced Malignancies
Celldex Therapeutics 70
Early research (Phase 1)Study completedNCT01989559
What this trial is testing

Booster Vaccination in Preventing Disease Recurrence in Previously Vaccinated Patients With Melanoma That Has Been Removed By Surgery

Who this might be right for
Recurrent MelanomaStage IA Skin MelanomaStage IB Skin Melanoma+7 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Looking for participantsNCT02830724
What this trial is testing

Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers

Who this might be right for
Pancreatic CancerRenal Cell CancerBreast Cancer+2 more
National Cancer Institute (NCI) 124
Testing effectiveness (Phase 2)Study completedNCT00019994
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00680589
What this trial is testing

Patients With Mouse Tyrp2 DNA: A Phase I Trial to Assess Safety and Immune Response

Who this might be right for
Melanoma
Memorial Sloan Kettering Cancer Center 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT03131908
What this trial is testing

Study of the Selective PI3K-Beta Inhibitor GSK2636771 in Combination With Pembrolizumab in Patients With Metastatic Melanoma and PTEN Loss

Who this might be right for
Melanoma and Other Malignant Neoplasms of SkinMetastatic Melanoma
M.D. Anderson Cancer Center 27
Load More Results